| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 718.00B | 715.28B | 717.25B | 628.11B | 539.61B |
| Gross Profit | 270.69B | 311.97B | 310.05B | 277.73B | 225.97B |
| EBITDA | 32.97B | 55.72B | 77.73B | 86.83B | 71.01B |
| Net Income | -91.28B | 6.12B | 32.57B | 44.94B | 42.68B |
Balance Sheet | |||||
| Total Assets | 1.08T | 1.11T | 1.15T | 1.05T | 1.04T |
| Cash, Cash Equivalents and Short-Term Investments | 158.72B | 166.71B | 222.55B | 212.58B | 370.28B |
| Total Debt | 220.91B | 193.57B | 166.71B | 134.02B | 130.06B |
| Total Liabilities | 488.92B | 471.29B | 462.02B | 431.92B | 439.60B |
| Stockholders Equity | 589.33B | 637.98B | 683.79B | 614.97B | 597.68B |
Cash Flow | |||||
| Free Cash Flow | -43.45B | -21.40B | -24.45B | -33.01B | 7.53B |
| Operating Cash Flow | -4.71B | 48.26B | 30.77B | 15.00M | 31.35B |
| Investing Cash Flow | -13.36B | -69.99B | -41.41B | -112.15B | -385.00M |
| Financing Cash Flow | 909.74M | -19.81B | -8.94B | -56.21B | -26.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $2.42B | 27.43 | 14.09% | 0.79% | 9.47% | 18.45% | |
72 Outperform | $428.63M | 12.84 | -3.57% | 3.22% | 17.59% | 68.88% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | $5.22B | 17.18 | 20.87% | 1.15% | 6.34% | -21.30% | |
47 Neutral | $3.78B | -6.97 | -14.01% | 2.16% | -4.44% | -1568.61% | |
47 Neutral | $114.75M | -6.98 | -5.76% | ― | -0.61% | -126.06% |